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Abstract Apoptosis or programmed cell death was induced in 
the human promyelocytic leukemia cell line HL-60 by UV 
irradiation or treatment with cytotoxic drugs (etoposide, 
camptothecin, melphalan or chlorambucil). These treatments 
caused a rapid increase in intracellular peroxide levels. 
Preincubation of HL-60 cells with the hydrogen peroxide-
scavenging enzyme catalase (500 U/ml) inhibited apoptosis due 
to UV irradiation or low concentrations of camptothecin, 
etoposide or melphalan, but did not protect against higher 
concentrations. In contrast, superoxide anion levels in the cells 
remained unchanged upon treatment with cytotoxic drugs, while 
UV irradiation led to a transient doubling in superoxide levels. 
Exogenous superoxide dismutase (400 U/ml) provided modest 
protection against UV irradiation and had no effect on cytotoxic 
drug-induced apoptosis. The results suggest that both hydrogen 
peroxide and superoxide anion may be involved in the induction 
of apoptosis by UV irradiation. On the other hand, while 
exposure to cytotoxic drugs induces a large increase in 
intracellular peroxide levels, catalase is able to protect the cells 
from apoptosis only when low concentrations of these compounds 
are used, thus indicating the involvement of other factors in this 
process, particularly at higher drug concentrations. 
© 1997 Federation of European Biochemical Societies. 
Key words: Apoptosis; Peroxide; Superoxide anion; 
Catalase; Superoxide dismutase 
1. Introduction 
Apoptosis or programmed cell death is a highly regulated 
form of cell death. Morphologically it is characterised by 
chromatin condensation, cell shrinkage and membrane bleb-
bing. Within the cell there occurs a carefully orchestrated 
cascade of enzymatic activities leading to protein and nucleic 
acid degradation. Although many components of the apopto-
sis jigsaw puzzle are continually being uncovered and put in 
place, many of the initial signals which are important in the 
induction of apoptosis, particularly by cytotoxic compounds, 
are still not fully understood. 
There is a wide variety of conditions which induce cells to 
die by apoptosis. These include physiological conditions, such 
as the binding of tumor necrosis factor to its receptor [1] or 
crosslinking of the Fas receptor [2]. The ability of a range of 
cytotoxic agents to kill cells in a controlled manner, i.e. by 
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reactive oxygen intermediate 
apoptosis, has been exploited in the chemotherapeutic treat-
ment of many cancers [3-9]. 
In order that the process of apoptosis may be manipulated 
in the treatment of various diseases such as cancer and AIDS, 
much effort has been expended in the search for a common 
signal which mediates the induction of this pathway. During 
recent years a large body of evidence has accumulated to 
suggest that oxidative stress may play a role as a common 
mediator of apoptosis [10,11]. For example, many chemother-
apeutic agents induce apoptosis while at the same time induc-
ing intracellular production of reactive oxygen intermediates 
(ROI). On the other hand, antioxidant molecules or molecules 
which enhance the endogenous antioxidant defence systems of 
the cells can inhibit apoptosis to varying extents [12-14]. 
Whether ROI production is the primary trigger for apop-
tosis in these cells or a contributory factor is not clear. How-
ever, in many instances the induction of oxidative stress is 
crucial to the process as seen from the protective effects af-
forded by antioxidant compounds [12,14]. Yet there remains 
many questions to be answered regarding the role played by 
oxidative stress in apoptosis. One of these questions is which 
ROIs are most important during apoptosis? 
The term ROI is a collective one that includes free radicals 
such as superoxide anion (02~), hydroxyl radicals (OH') and 
also some nonradical derivatives of oxygen, such as hydrogen 
peroxide (H2Oa). Both superoxide and hydrogen peroxide are 
relatively unreactive compared with hydroxyl radicals which 
can cause damage to most biological molecules, including 
DNA, proteins and lipid membranes [15]. Superoxide may 
be important in apoptosis as it reacts with nitric oxide 
(NO') to yield peroxynitrite, which has been found to be toxic 
to HL-60 cells [16]. 
The cytotoxic agents used in this study were chosen for 
their usefulness in anticancer treatments [3-9]. Firstly, camp-
tothecin and etoposide are topoisomerase I and II inhibitors, 
respectively. They inhibit these enzymes by stabilization of the 
cleavable complex between the enzyme and DNA and lead to 
the formation of protein-bound DNA breaks. It is thought 
that cytotoxicity occurs because the cells are prevented from 
completing the S-phase or undergoing mitosis. The other 
apoptosis-inducing agents used, melphalan and chlorambucil, 
are alkylating agents. DNA is generally thought to be the 
principle molecular target of alkylating agents [17,18] leading 
to an increased the rate of depurination. It is likely that the 
damage caused to the cell by alkylating agents triggers the cell 
to engage the apoptotic pathway. However, there is evidence 
that there are other mechanisms involved [19-21]. The induc-
tion of oxidative stress is one potential candidate particularly 
since antioxidant compounds can inhibit apoptosis by topo-
isomerase inhibitors [12] and the toxicity of melphalan is 
highly dependent on the glutathione content [20,21]. 
The majority of work performed to date has involved the 
use of non-specific antioxidant compounds to inhibit apopto-
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sis. Alternatively workers have used end-point measurements 
such as lipid peroxidation or measurement of protein oxida-
tion to demonstrate an involvement of oxidative stress. In this 
paper we investigate the relative importance of hydrogen per-
oxide and superoxide anions in the initiation of apoptosis by a 
number of anticancer agents. Firstly, the fluorescent probes, 
2',7'-dichlorofluorescin diacetate ( D C F H / D A ) and hydroethi-
dine were employed to evaluate intracellular production of 
peroxides and superoxide anion, respectively, upon induction 
of apoptosis. Secondly, we tested the ability of catalase and 
superoxide dismutase, which are specific for the degradation 
of hydrogen peroxide and of superoxide, respectively, to in-
hibit apoptosis. 
2. Materials and methods 
2.1. Cell culture 
The human promyelocytic HL-60 leukemic cell line [22] was used. 
Cells were cultured in RPMI-1640 medium (Gibco, UK) supple-
mented with 10% FCS (Biochrom KG, Germany) and 2 mM gluta-
mine. Cells were maintained at 37°C in a humidified 5% C0 2 atmos-
phere. 
2.2. Treatment of cells with cytotoxic agents 
HL-60 cells (5X 105/ml) were seeded in 24-well plates (Nunc, Ros-
kilde, Denmark) and exposed to various concentrations of cytotoxic 
agents: camptothecin (0.05-0.5 |ig/ml), etoposide (5-20 |xg/ml), mel-
phalan (20-60 |Xg/ml) and chlorambucil (80-100 |ig/ml). Stock solu-
tions of these compounds were made in dimethylsulfoxide (DMSO) 
and diluted by at least 1 in 1000 to ensure solvent levels not greater 
than 0.1%. Alternatively cells were exposed from below to a 302 nm 
UV transilluminator source at a distance of 2.5 cm for 15-60 s at 
room temperature. Cells were then incubated at 37°C and assessed for 
apoptosis or ROI levels at the indicated times. In some experiments 
cells were incubated with either catalase (Bovine liver, EC 1.11.1.6, 
Sigma) (500 U/ml) or superoxide dismutase (Bovine erythrocyte, EC 
1.15.1.1, Sigma) (400 U/ml) for 10 min prior to treatment with cyto-
toxic agents. 
2.3. Cell viability and morphology 
Cell number was assessed using a Neubauer haemocytometer, and 
viability was determined by the ability of cells to exclude try pan blue. 
Cell morphology was evaluated by staining cytocentrifuge prepara-
tions with Rapi-Diff II (Paramount reagents Ltd., UK). Apoptotic 
cells were identified as described previously [23]. 
2.4. DNA isolation and electrophoresis 
DNA was isolated by centrifuging cells at 200 X g for 5 min at room 
temperature. Cell pellets (containing 5 X105 cells) were resuspended in 
20 ml of lysis buffer which contained 20 mM EDTA, 100 mM Tris-
HC1, pH 8.0, and 0.8% (w/v) sodium lauryl sarcosinate. RNAse A (10 
(0,1 of 1 mg/ml prepared in 0.1 M sodium acetate and 0.3 mM EDTA, 
pH 4.8) was added. The samples were incubated overnight at 37°C. 
Then 10 ml of proteinase K (20 mg/ml in distilled water) was added 
and the samples were heated at 50°C for 1.5 h. Prior to loading onto 
agarose gels 5 ml of loading buffer (10 mM EDTA, 0.25% (w/v) 
bromophenol blue and 50% (w/v) glycerol) was added to each sample. 
DNA was electrophoresed in 1.5% agarose gels at 55V for 3-4 h in 
buffer containing 2 mM EDTA, 89 mM Tris-HCl and 89 mM boric 
acid, pH 8.0. Gels were cast in apparatus supplied by CBS Scientific 
Co. (CA, USA). 
2.5. Measurement of intracellular peroxide levels 
Peroxide levels were assessed using the method of [24] as previously 
described [12]. Briefly cells (5xl05/ml) were incubated with 5 uM 
DCFH/DA (Molecular Probes), made as a 10 mM stock in DMSO, 
for 1 h at 37°C. Cells were treated with apoptosis-inducing agents 
either before, after or during the loading period (depending on the 
time point at which ROI measurement was to be made). Peroxide 
levels were measured using a Becton Dickinson FACScan flow cytom-
eter with excitation and emission settings of 488 and 530 nm, respec-
tively. 
2.6. Measurement of intracellular superoxide anion 
Superoxide anion levels were measured using an adaptation of the 
method employed by [25]. We used the dye hydroethidine (Molecular 
Probes) which is oxidised by superoxide anion within the cell to pro-
duce ethidium bromide, which fluoresces when it intercalates into 
DNA. Briefly, cells (5Xl05/ml) were incubated with 10 uM hydro-
ethidine (Molecular Probes) (made as a 10 mM stock in DMSO) for 
15 min at 37°C. Cells were treated with apoptosis-inducing agents 
either before, after or during the loading period (depending on the 
time point at which ROI measurement was to be made). Intracellular 
superoxide anion levels were assessed by measuring the fluorescence 
due to ethidium bromide (i.e. FL2) using a Becton Dickinson FACS-
can flow cytometer with excitation and emission settings of 488 and 
600 nm, respectively. 
3. Results 
3.1. Peroxide and superoxide production upon UV irradiation 
Oxidative stress has been implicated in apoptosis in a num-
ber of systems. In the present study HL-60 cells were treated 
with UV irradiation or a number of cytotoxic drugs. Exposure 
of HL-60 cells to UV irradiation (15-60 s) induced the mor-
phological changes typical of apoptosis after 4 h (Fig. 1). 
Similar results were obtained upon exposure to camptothecin 
(0.05-0.5 ug/ml), etoposide (5-20 ug/ml), melphalan (20-60 
Ug/ml) or chlorambucil (80-100 u\g/ml) (data not shown). 
Treatment of the cells with UV irradiation also caused a 
time-dependent increase in intracellular peroxide production 
as demonstrated by an increase in fluorescence due to oxida-
tion of D C F H - D A (Fig. 2A). In addition, there was a small, 
transient increase in intracellular superoxide levels which was 
monitored by an increase in fluorescence due to the oxidation 
of hydroethidine (Fig. 2B). Both of these ROIs were induced 
Fig. 1. Morphological features of (A) untreated HL-60 cells or (B) 
cells exposed to UV irradiation for 15 s. 
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rapidly prior to any other noticeable changes, indicating their 
candidacy as signals for initiation of apoptosis. 
3.2. Protection by catalase against UV irradiation 
In order to ascertain whether these ROIs are important for 
the induction of apoptosis by UV irradiation we decided to 
evaluate the ability of ROI-scavenging enzymes to protect the 
cells from apoptosis. Firstly, the hydrogen peroxide-scaveng-
ing enzyme, catalase was used. This enzyme converts two 
molecules of hydrogen peroxide into two molecules of water 
and one of oxygen. Catalase was found to cause an increased 
rate of clearance of peroxide from UV irradiated cells (Fig. 3). 
As the enzyme is not cell-permeable (in contrast to hydrogen 
peroxide) this is probably due to a removal of hydrogen per-
oxide from the culture medium which would promote the exit 
of hydrogen peroxide from the cellular cytoplasm to establish 
equilibrium [26]. 
In accord with this finding, catalase conferred protection on 
HL-60 cells against UV-induced apoptosis as assessed either 
by morphological criteria (Fig. 4A) or by the degree of DNA 
laddering produced by the cells (Fig. 4B). In contrast, super-
oxide dismutase, which catalyzes the dismutation of superox-
ide into hydrogen peroxide, was found to confer only slight 
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Fig. 2. A: Time course of peroxide levels in HL-60 cells treated 
with UV irradiation. HL-60 cells were UV-irradiated for 60 s, and 
intracellular peroxide levels were detected by measuring the relative 
FL1 values due to oxidation of DCFH/DA. B: Superoxide produc-
tion in cells irradiated with UV for 60 s. Superoxide levels were de-
tected by the relative FL2 values due to oxidation of hydroethidine. 
Measurements were made at 0 (untreated cells), 2 or 5 min after 
UV irradiation as indicated. 
10' 10" 10v 
FL1-H 
Fig. 3. Catalase increases clearance rate of peroxides from UV irra-
diated cells. HL-60 cells were either untreated (shaded trace; omit-
ted from the second and third plots for the sake of clarity), or UV-
irradiated for 60 s in the absence (solid line) or presence (broken 
line) of catalase (500 U/ml). Peroxide levels (FL1 values) were meas-
ured at various times thereafter as indicated. Peroxide levels in cells 
treated with catalase (500 U/ml) were superimposable on untreated 
cells and these traces were omitted for clarity. 
protection on the cells against UV-induced apoptosis (Fig. 5). 
This degree of protection was not significant. 
3.3. ROI involvement during cytotoxic drug-induced apoposis 
Treatment of HL-60 cells with cytotoxic drugs also caused 
an increase in intracellular peroxide levels (Fig. 6). This in-
crease was time and concentration-dependent (Fig. 6 and data 
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not shown). The increase was rapid with peroxide levels de-
creasing gradually, particularly in the case of camptothecin 
and etoposide, whereas levels remained relatively high in the 
case of melphalan and chlorambucil. In contrast to UV irra-
diation, the use of cytotoxic drugs, camptothecin and etopo-
side, did not produce any increase in intracellular levels of 
superoxide (Fig. 7) up to 60 min. In fact there was a slight 
decrease in levels of this ROI. There was no alteration in 
superoxide levels in cells treated with melphalan (40 |o.g/ml) 
or chlorambucil (100 ug/ml) up to 10 min (data not shown). 
Catalase, provided partial inhibition against the induction 
of apoptosis by cytotoxic drugs (Fig. 8). Protection was more 
evident at low concentrations camptothecin (0.05 ug/ml), eto-
poside (5 Ug/ml) or melphalan (40 u,g/ml) while there was no 
protection from chlorambucil-induced apoptosis. On the other 
hand, superoxide dismutase did not have any protective effects 
under these conditions (data not shown). 
1 0 0 
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4. Discussion 
The present study demonstrates the involvement of hydro-
gen peroxide in the induction of apoptosis by UV irradiation, 
UV irradiation, sec 
Fig. 5. Lack of inhibition of UV-induced apoptosis by superoxide 
dismutase. HL-60 cells were UV-irradiated for the indicated lengths 
of time in the presence or absence of superoxide dismutase (400 U/ 
ml). After 4 h the % apoptosis was determined by morphological 
means from cytospin preparations of the cells. 
Fig. 4. Inhibition of UV-induced apoptosis by catalase (500 U/ml). 
HL-60 cells were UV-irradiated for the indicated lengths of time in 
the presence or absence of catalase (500 U/ml). A: After 4 h the % 
apoptosis was determined by morphological means from cytospin 
preparations of the cells. B: The degree of DNA laddering was de-
termined. HL-60 cells were UV-irradiated for 0 (lanes 1 and 5), 15 s 
(lanes 2 and 6), 30 s (lanes 3 and 7) or 60 s (lanes 4 and 8) in the 
presence (lanes 5 to 8) or absence (lanes 1 to 4) of catalase (500 
U/ml). 
while the involvement of superoxide may be by an indirect 
mechanism. For example, it may act as an intermediate in the 
formation of hydrogen peroxide or of hydroxyl radicals. The 
involvement of hydrogen peroxide is seen both by the large 
rapid increase in intracellular peroxide levels as determined by 
fluorometric methods, and further by the protective effect of 
exogenous catalase. The results obtained are in agreement 
with a number of other workers who have observed that cat-
alase acts as an anti-apoptotic factor in conditioned medium 
to block density-dependent apoptosis [27] and that it delays 
the induction of apoptosis by dexamethasone in murine thy-
mocytes [28]. 
In contrast, intracellular superoxide anion levels increased 
only slightly and transiently in UV-irradiated cells. Exogenous 
superoxide dismutase provided only slight protection. How-
ever the notion that this ROI is involved in apoptosis cannot 
by completely ruled out. For example, it may be an important 
intermediate in the generation of increased levels of either 
hydrogen peroxide (due to the activity of intracellular super-
oxide dismutases). Indeed the transient nature of superoxide 
anion accumulation during apoptosis may result from a high 
rate of superoxide dismutase activity within the cell. Moreover 
hydroxyl radicals can be generated from superoxide anions by 
the metal-catalysed Fenton or Haber-Weiss reactions. It has 
been suggested that superoxide production serves as an early 
signal, rather than a toxic agent, to mediate apoptosis, as 
injection of Cu/Zn superoxide dismutase into sympathetic 
neurons delayed apoptosis due to deprivation of nerve growth 
factor [29] and addition of nerve growth factor back to the 
culture medium after the period of peak ROI generation pre-
vented apoptosis. 
Treatment of the cells with various cytotoxic drugs induced 
a large and rapid increase in the intracellular levels of perox-
ides. Interestingly, catalase is capable of protecting the cells 
from apoptosis induced by low concentrations of these com-
A. Gorman et al.lFEBS Letters 404 (1997) 27-33 31 
3 
•a 
II 
200 200 
Time, min 
125 
100-
7 5 -
200 
5 0 -
2 5 -
100 150 200 
Time, min Time, min 
Fig. 6. Time course of peroxide levels in HL-60 cells treated with cytotoxic drugs. Cells were treated with the following concentrations of cyto-
toxic agents: etoposide, 10 |J,g/ml; camptothecin, 0.1 |J,g/ml; melphalan, 60 |ig/ml; chlorambucil, 100 ug/ml. Intracellular peroxide levels were 
detected by measuring the relative FLl values due to oxidation of DCFH/DA. 
pounds while failing to protect against higher concentrations. 
One possible explanation for this is that hydrogen peroxide is 
not the main peroxide produced by these treatments. Further-
more the results indicate a mixed action of cytotoxic drugs in 
inducing apoptosis, of which the induction of oxidative stress 
is a contributory factor. Another interesting observation is 
that the time course of peroxide production in cells treated 
with either topoisomerase inhibitors or alkylating agents was 
markedly different. Both classes of drugs led to a rapid in-
crease in intracellular peroxide levels, but in the case of topo-
isomerase inhibitors this decreased to basal levels over a peri-
od of about 2 h while remaining at high levels for at least 2.5 
h after treatment with alkylating agents. In contrast, even 
though UV irradiation led to higher levels of peroxide, these 
had reduced to basal levels by 1 h. The greater sensitivity of 
UV and topoisomerase inhibitor-induced apoptosis to catalase 
inhibition may reflect the more transient nature of peroxide 
generation by these compounds and suggests that the peroxide 
produced may be hydrogen peroxide. In contrast to peroxide, 
superoxide anions were not elevated during the induction of 
apoptosis by cytotoxic compounds. This suggests either a lack 
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Fig. 7. Lack of superoxide production by cytotoxic agents. Cells 
were treated with the following concentrations of cytotoxic agents: 
etoposide, 10 |J,g/ml; camptothecin, 0.5 |xg/ml. 
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Fig. 8. Inhibition by catalase (500 U/ml) of the induction of apoptosis by cytotoxic agents. HL-60 cells were incubated with the indicated con-
centrations of apoptosis-inducing drugs in the presence (shaded bars) or absence (open bars) of catalase (500 U/ml). After 4 h the % apoptosis 
was determined by morphological means from cytospin preparations of the cells. 
of involvement or their rapid removal by cellular superoxide 
dismutases. 
Although we demonstrate here a minimal involvement of 
hydrogen peroxide and superoxide anion in drug-induced 
apoptosis, we have previously shown that a number of anti-
oxidant compounds can protect HL-60 cells from both cyto-
toxic drug or UV-induced apoptosis [12]. These agents, i.e. 
butylated hydroxyanisole (BHA), cysteamine or particularly 
pyrrolidinedithiocarbamate (PDTC) give better protection 
than either catalase or superoxide dismutase. This is likely 
to be at least partly due to the necessity for hydrogen peroxide 
and superoxide anion to diffuse out of the cells in order to 
allow protection while the antioxidant molecules used are tak-
en up by cells and thus have access to the intracellular com-
partments where ROIs are produced. It is also likely to be at 
least partly due to the multiple biological effects of antioxi-
dant compounds, e.g. PDTC (which has metal-chelating prop-
erties and ability to react with sulfhydryl groups on other 
molecules) compared with the specific nature of the ROI-scav-
enging enzymes used in the present study. It has also been 
found that increased intracellular glutathione (part of the 
cell's antioxidant defence mechanism) can decrease the sensi-
tivity of cells to melphalan [20,21]. 
The source of peroxide production in cells treated with 
cytotoxic drugs is not known. There is evidence for the direct 
production of free radicals by toxic foreign compounds, e.g. 
etoposide can be metabolized to free-radical derivatives which 
may contribute to its cytotoxicity [30]. It has been postulated 
that cytotoxic drugs can generate elevated level of ROIs 
through interference with mitochondrial function as this is a 
main site of free-radical production in cells. However, we have 
shown previously that collapse of the mitochondrial trans-
membrane potential is a late rather than an early event in 
apoptosis by cytotoxic drugs such as camptothecin [31]. 
Under normal circumstances, the major source of free rad-
icals in cells is electron leakage from electron transport chains 
associated with mitochondrial membranes and the endoplas-
mic reticulum, to generate superoxide anions [32]. The nuclear 
membrane also contains electron transport systems which may 
produce free radicals. Under physiological conditions super-
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oxide is readily converted to hydrogen peroxide by superoxide 
dismutase. The enzymes N A D P H oxidase and xanthine oxi-
dase are also two well known sources of superoxide genera-
tion [33,34]. Although superoxide does not appear to be cru-
cial for apoptosis we have previously shown that inhibition of 
N A D P H oxidase by diphenyliodinium can protect HL-60 cells 
from apoptosis by UV irradiation, hydrogen peroxide or ac-
tinomycin D [31] suggesting that at least one of the potential 
sources of ROIs under these conditions is N A D P H oxidase. 
Superoxide anion produced in this way may be rapidly con-
verted to hydrogen peroxide by superoxide dismutase. Its im-
portance in the induction of apoptosis by UV and cytotoxic 
drugs may also arise from the production of hydroxyl radi-
cals. These can be generated by the metal-catalysed Fenton 
reaction or through interaction with superoxide in the Haber-
Weiss reaction. 
It should be remembered that hydrogen peroxide is not an 
oxygen free radical and is relatively unreactive. It may, how-
ever, act as a metabolic signal, possibly by oxidizing specific 
protein thiol groups and triggering intracellular events leading 
to apoptosis. For example it can cause activation of the nu-
clear regulatory protein N F k B [35,31]. Other transcription 
factors, such as fos and myc [36], are also sensitive to redox 
regulation and thus may act as signalling molecules in the 
apoptosis process. 
Overall the results obtained suggest that induction of apop-
tosis by UV irradiation proceeds through a ROI-dependent 
pathway, where hydrogen peroxide is an important intermedi-
ate presumably being converted to the more toxic hydroxyl 
radical. On the other hand, while the induction of apoptosis 
by cytotoxic drugs does appear to be mediatied by an ROI-
dependent pathway, the results presented here indicate a 
mixed action of these agents in inducing apoptosis. It is clear 
that antioxidants can protect cells under these conditions 
[12,20,21]. However, the limited protective effects of catalase 
suggests that at high concentrations of drugs there are other 
effects of these drugs apart from inducing oxidative stress, i.e. 
damage to proteins and to D N A , which the use of catalase 
alone cannot overcome. However, it should be noted that 
antioxidant molecules (with the exception of P D T C , which 
as well as being an 'antioxidant ' , may inhibit the apoptotic 
process itself [37]) are only moderately protective against cy-
totoxic drugs relative to their ability to inhibit UV or hydro-
gen peroxide-induced apoptosis [12]. 
In conclusion, the results are interesting in terms of our 
understanding of the mechanism of UV and cytotoxic drug-
induced apoptosis in leukemic cells. They imply that hydrogen 
peroxide is particularly important in UV-induced cell death 
and that the duration of elevated peroxide levels may be im-
portant in determining whether the cells are responsive to 
protection by catalase. 
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